CELESTE FRALICK

Profile

First Name

: CELESTE

Middle Name

:

Last Name

: FRALICK

Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity, Debt 
2025-03-05 
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2024-06-30 
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
 
2024-01-26